Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial

Rothschild, Sacha; Bucher, Stephan E; Bernier, Jacques; Aebersold, Daniel M; Zouhair, Aberrahim; Ries, Gerhard; Lombrieser, Norbert; Lippuner, Thomas; Lütolf, Urs M; Glanzmann, Christoph; Ciernik, I Frank (2011). Gefitinib in Combination with Irradiation with or Without Cisplatin in Patients with Inoperable Stage III Non-Small Cell Lung Cancer: A Phase I Trial. International journal of radiation oncology, biology, physics, 80(1), pp. 126-32. New York, N.Y.: Elsevier 10.1016/j.ijrobp.2010.01.048

Full text not available from this repository.

To establish the feasibility and tolerability of gefitinib (ZD1839, Iressa) with radiation (RT) or concurrent chemoradiation (CRT) with cisplatin (CDDP) in patients with advanced non-small cell lung cancer (NSCLC).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Aebersold, Daniel Matthias

ISSN:

0360-3016

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:08

Last Modified:

02 Mar 2023 23:20

Publisher DOI:

10.1016/j.ijrobp.2010.01.048

PubMed ID:

20646869

Web of Science ID:

000290006300019

URI:

https://boris.unibe.ch/id/eprint/398 (FactScience: 198394)

Actions (login required)

Edit item Edit item
Provide Feedback